Blocking PHGDH overcomes dabrafenib resistance through metabolic rewiring in thyroid cancer
An unexpected metabolic vulnerability may offer a new way to outmaneuver one of the most aggressive forms of thyroid cancer. In a study published in Cell Death Discovery, researchers S.Y. Kim...
Read moreDetails






















